Skip to content

2nd Transatlantic Exchanges in Immuno-Oncology

Hybrid Conference was held in Paris the Friday May 5, 2023

Artificial Intelligence and Data Science in Oncology

-

Opening and Welcome

Toni Choueiri MD, Chair - Dana Farber Cancer Institute
Karim Fizazi MD, PhD, Chair - Gustave Roussy
Fabrice Barlesi MD, PhD - Gustave Roussy

Session 1: Moderators

Fabrice André MD, PhD - Gustave Roussy
Eliezer Van Allen MD - Harvard Medical School - Dana Farber Cancer Institute
-

Deep learning in Computational Oncology: Methods and Clinical Perspectives

Paul-Henry Cournède PhD - CentraleSupélec - Université Paris Saclay
-

Applications of AI in Oncology: From Screening to Treatment and Follow-Up

Jean-Emmanuel Bibault MD, PhD - HEGP
-

Deep Learning Methods for Medical Imaging in Precision Oncology

Maria Vakalopoulou MD, PhD - CentraleSUpélec - Université Paris Saclay
-

Q&A and discussion

-

Digital Twins for Predictive Oncology

Benoît Gallix MD, PhD - Hôpital Américain - Paris
-

AI in Imaging: Challenges and Opportunities

Valérie Paradis MD, PhD - Hôpital Beaujon
-

Somatic evolution of human cancer

Franziska Michor PhD - Dana Farber Cancer Institute - Harvard University
-

Q&A and discussion

Session 2: Moderators

Franziska Michor PhD - Dana Farber Cancer Institute - Harvard University
Paul-Henry Cournède PhD - CentraleSUpélec - Université Paris Saclay
-

Welcome and Introductions

-

Cancer Evolution Meets Computational Oncology

Charles Swanton MBPhD, FRCP, FMedSci, FRS - Francis Crick Institute
-

Genomes and AI - Chromatin Organization as a Biomarker for Cancer

Caroline Uhler PhD - Broad Institute of MIT and Harvard
-

AI based pathology predicts origin of cancer of unknown primary

Faisal Mahmood PhD - Brigham and Women’s Hospital
-

Q&A and discussion

-

Towards AI-driven immunoradiotherapy

Charlotte Robert PhD - Gustave Roussy
-

AI for breast cancer screening: From algorithms to clinical integration

Bill Lotter PhD - Dana Farber Cancer Institute - Harvard Medical School
-

AI for cancer symptoms monitoring: Supporting patient needs and lowering burden

Charlotta Lindvall MD, PhD - Dana Farber Cancer Institute - Harvard Medical School
-

Q&A and Discussion

-

Concluding remarks

Karim Fizazi MD, PhD, Chair - Gustave Roussy
Toni Choueiri MD, Chair - Dana Farber Cancer Institute